Thomas Winder

3.1k total citations
35 papers, 2.0k citations indexed

About

Thomas Winder is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Thomas Winder has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 11 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Thomas Winder's work include Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Thomas Winder is often cited by papers focused on Colorectal Cancer Treatments and Studies (15 papers), Gastric Cancer Management and Outcomes (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). Thomas Winder collaborates with scholars based in United States, Switzerland and Austria. Thomas Winder's co-authors include Heinz‐Josef Lenz, Yan Ning, Dongyun Yang, Melissa J. LaBonte, Wu Zhang, Peter M. Wilson, Georg Lurje, Heinz‐Josef Lenz, Alexandra Pohl and Armin Gerger and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Thomas Winder

34 papers receiving 2.0k citations

Peers

Thomas Winder
Esther Bertrán Spain
Alessandro Morotti Italy
Kai He United States
Peter Shintaku United States
Christian F. Meyer United States
Verena Tischler Switzerland
Hirokazu Okayama Japan
Koichi Hamada Japan
Kenneth F. Grossmann United States
Lisa Happerfield United Kingdom
Esther Bertrán Spain
Thomas Winder
Citations per year, relative to Thomas Winder Thomas Winder (= 1×) peers Esther Bertrán

Countries citing papers authored by Thomas Winder

Since Specialization
Citations

This map shows the geographic impact of Thomas Winder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Winder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Winder more than expected).

Fields of papers citing papers by Thomas Winder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Winder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Winder. The network helps show where Thomas Winder may publish in the future.

Co-authorship network of co-authors of Thomas Winder

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Winder. A scholar is included among the top collaborators of Thomas Winder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Winder. Thomas Winder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reichinger, Andreas, Hossein Taghizadeh, Patrick Kirchweger, et al.. (2025). NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data. ESMO Open. 10(10). 105827–105827.
2.
Taghizadeh, Hossein, Gerald Webersinke, Stefan Kasper, et al.. (2024). Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data. Cancer Immunology Immunotherapy. 73(12). 251–251. 2 indexed citations
3.
4.
Dosso, Sara De, Alexander Siebenhüner, Thomas Winder, et al.. (2021). Treatment landscape of metastatic pancreatic cancer. Cancer Treatment Reviews. 96. 102180–102180. 120 indexed citations
5.
6.
Tan, Christopher, M. Jody Westbrook, Rebecca Truty, et al.. (2020). Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders. Genetic Testing and Molecular Biomarkers. 24(10). 616–624. 11 indexed citations
7.
Unseld, Matthias, Alexander Siebenhüner, Andreas Gleiß, et al.. (2018). Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and Regorafenib. Clinical Colorectal Cancer. 17(4). 274–279. 12 indexed citations
8.
Szkandera, Joanna, Tatjana Stojaković, Peter Kornprat, et al.. (2018). Elevated amylase in plasma represents an adverse prognostic marker in patients with metastatic pancreatic cancer. Wiener klinische Wochenschrift. 130(19-20). 569–574. 2 indexed citations
9.
Willer, Tobias, Hane Lee, Mark Lommel, et al.. (2012). ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome. Nature Genetics. 44(5). 575–580. 179 indexed citations
10.
Stratton, Robert F., et al.. (2012). Metastatic medulloblastoma in an adolescent with Simpson–Golabi–Behmel syndrome. American Journal of Medical Genetics Part A. 158A(10). 2534–2536. 18 indexed citations
11.
12.
Gerger, Armin, Anthony B. El-Khoueiry, Wu Zhang, et al.. (2011). Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 17(17). 5783–5792. 72 indexed citations
13.
Lang, Alois, Heinz Drexel, Nicole Stark, et al.. (2011). Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF. Journal of Molecular Diagnostics. 13(1). 23–28. 90 indexed citations
14.
Winder, Thomas, Wu Zhang, Dongyun Yang, et al.. (2010). Germline Polymorphisms in Genes Involved in the IGF1 Pathway Predict Efficacy of Cetuximab in Wild-type KRAS mCRC Patients. Clinical Cancer Research. 16(22). 5591–5602. 43 indexed citations
15.
16.
Ning, Yan, Philipp Manegold, Young Kwon Hong, et al.. (2010). Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivityin vitroandin vivoin colon cancer cell line models. International Journal of Cancer. 128(9). 2038–2049. 355 indexed citations
17.
Winder, Thomas & Heinz‐Josef Lenz. (2010). Molecular predictive and prognostic markers in colon cancer. Cancer Treatment Reviews. 36(7). 550–556. 52 indexed citations
18.
Laing, Nigel G., Danielle E. Dye, Carina Wallgren‐Pettersson, et al.. (2009). Mutations and polymorphisms of the skeletal muscle α-actin gene (ACTA1). Human Mutation. 30(9). 1267–1277. 173 indexed citations
19.
Winder, Thomas & John N. Nishio. (1995). Early Iron Deficiency Stress Response in Leaves of Sugar Beet. PLANT PHYSIOLOGY. 108(4). 1487–1494. 59 indexed citations
20.
Winder, Thomas, James C. Anderson, & Martin H. Spalding. (1992). Translational Regulation of the Large and Small Subunits of Ribulose Bisphosphate Carboxylase/Oxygenase during Induction of the CO2-Concentrating Mechanism in Chlamydomonas reinhardtii. PLANT PHYSIOLOGY. 98(4). 1409–1414. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther Bertrán Breakdown of academic impact, for papers by Alessandro Morotti Breakdown of academic impact, for papers by Kai He Breakdown of academic impact, for papers by Peter Shintaku Breakdown of academic impact, for papers by Christian F. Meyer Breakdown of academic impact, for papers by Verena Tischler Breakdown of academic impact, for papers by Hirokazu Okayama Breakdown of academic impact, for papers by Koichi Hamada Breakdown of academic impact, for papers by Kenneth F. Grossmann Breakdown of academic impact, for papers by Lisa Happerfield
Rankless by CCL
2026